Proteon Therapeutics

company

Number of Lead Investors

Number of Investors

Proteon Therapeutics is funded by 20 investors. Aqua Spark and PFR Life Science are the most recent investors.

Investor Name	Lead Investor	Funding Round
Aqua Spark	Yes	Post-IPO Equity
PFR Life Science	Yes	Post-IPO Equity
Nutreco	Yes	Post-IPO Equity
European regional development fund (ERDF)	Yes	Grant
Deepfield	Yes	Post-IPO Equity
Abingworth	Yes	Series D
Montis Capital	-	Post-IPO Equity
Seventure Partners	-	Post-IPO Equity
Life Sciences Fund	-	Series D
Inbio Ventures	-	Series D
Bessemer Venture Partners	-	Series D
Devon Park BioVentures	-	Series D
Intersouth Partners	-	Series D
MPM Capital	-	Series D
Pharmstandard	-	Series D
Prism Venture Management	-	Series D
Skyline Ventures	-	Series D
TVM Capital	-	Series D
Vectis Healthcare & Life Sciences Fund	-	Series D
MPM Bio IV NVS Strategic Fund	-	Series B